• Depression, treatment-resistant depression & anxiety

• PTSD

• High risk of suicidal ideation

• High-risk in community and long-term care settings

• Users of online health screening platforms

The Mind-Body Interface Research Center and Depression Center at Tainan Municipal An-Nan Hospital, China Medical University, led by Professor Kuan-Pin Su, has established a scalable and replicable hospital–community care model to address Taiwan's suboptimal depression treatment and high relapse rates caused by early follow-up discontinuation. By adopting MBC, the center integrates standardized scales (HAM-D, PHQ-9, BDI) with multimodal data (wearable devices, HRV, EEG) for longitudinal tracking across symptom, physiological, and behavioral domains, enhancing clinical decision-making. Treatments are stratified based on biopsychosocial needs, offering personalized, evidence-based interventions including accelerated theta-burst TMS , CES, tPBM, traditional Chinese acupuncture, and internationally recognized Omega-3 fatty acid therapy. To improve continuity of care and patient engagement, the center developed a digital mental health assessment platform and online self-care programs. This approach achieved exceptional follow-up rates of 86% at 1 month, 63% at 3 months, and 51% at 6 months, significantly outperforming national insurance benchmarks. Furthermore, patient satisfaction reached 94–96%, and suicidal ideation markedly declined, with the proportion of patients reporting no suicidal thoughts increasing from 51% to 79%. Aligned with national health policies, the center continues to advance a sustainable, precise, and patient-centered model of integrated mental healthcare.

• MBC (Measurement-Based Care) model

• Leading nutritional and transcranial magnetic stimulation therapies

• Providing integrated healthcare services to deliver personalized care plans

• Traditional Chinese medicine and acupuncture

• Non-invasive brain stimulation therapy

• Online mental and behavioral health screening platform

• Outpatient services for over 3,000 cases

• More than 300 patients have received rTMS services

• 2024 TMS treatments: 1,395 sessions

• 2025 TMS treatments: 941 sessions

• A total of 6,674 screenings were conducted via the online screening platform

• One-month follow-up rate 86% (NHI 52%)

• Three-month rate 63% (NHI 18%)

• Six-month rate 51%

• A reduction in suicidal ideation was observed after nutritional therapy, improving from

• 51% to 79%

• Outpatient cases undergo standardized psychological assessments

• Implement shared decision-making (SDM)

• Standardization of Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment

• Protocols

• A multi-channel outpatient follow-up reminder system (integrating LINE messaging,

• phone calls, and in-clinic reminders)

• Standardized assessments before, during, and after treatment

• Overall satisfaction 95%

• Staff attitude 96%

• Timeliness 96%

• Environment comfort 96%

• Physician communication 92%

• Adequate consultation time 92%

• Professor Su Kuan-Pin has served as a member of the Presidential Office Health

• Taiwan Promotion Committee since 2024

• 21st Yu-Hsiang Tech Award

• Intl guidelines: ISNPR/WFSBP/CANMAT

• Ranked joint first globally in Omega-3 research within the field of depression

• Ranked 4th worldwide and 1st in Taiwan among institutions conducting Omega-3

• research

• Taiwan Clinical TMS Society Best Paper

• Provision of precision, personalized healthcare plans

• Promotion of population-wide mental health prevention strategies

• Collaboration with primary care clinics, long-term care facilities, and social welfare

• organizations

• Development of standardized integrated care processes